We observed a 40% reduction in Shp1 protein levels in peripheral blood cells from tumor-bearing Ptpn6fl/fl ERT2-Cre mice following tamoxifen treatment (Figure 4F), and mice began to show bodyweight loss consistent with development of the motheaten phenotype (Supplementary Figure 5D). This evidence concerns the gene PTPN6 and neoplasm.